Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Twin combination of Omicron and Delta variants triggering a tsunami wave of ever high surges in COVID‐19 cases: A challenging global threat with a special focus on the Indian subcontinent
Ranjan K. Mohapatra, Ruchi Tiwari, Ashish K. Sarangi, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1761-1765
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Emergence of Omicron third lineage BA.3 and its importance
Perumal Arumugam Desingu, K. Nagarajan, Kuldeep Dhama
Journal of Medical Virology (2022) Vol. 94, Iss. 5, pp. 1808-1810
Open Access | Times Cited: 146
Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113522-113522
Open Access | Times Cited: 96
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions
Manish Dhawan, Abhilasha Sharma, Priyanka Choudhary, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 91
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 944-944
Open Access | Times Cited: 70
A new generation Mpro inhibitor with potent activity against SARS-CoV-2 Omicron variants
Chong Huang, Huiping Shuai, Jingxin Qiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 54
The SARS‐CoV‐2 omicron wave is indicating the end of the pandemic phase but the COVID‐19 will continue
Sohel Daria, Md. Rabiul Islam
Journal of Medical Virology (2022) Vol. 94, Iss. 6, pp. 2343-2345
Open Access | Times Cited: 59
SARS‐CoV‐2 and its variants of concern including Omicron: A never ending pandemic
Ranjan K. Mohapatra, Satwik Kuppili, Tarun Kumar Suvvari, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 769-788
Open Access | Times Cited: 58
Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective
Ranjan K. Mohapatra, Venkataramana Kandi, Sarika Verma, et al.
ChemBioChem (2022) Vol. 23, Iss. 9
Open Access | Times Cited: 51
The recombinant variants of SARS‐CoV‐2: Concerns continues amid COVID‐19 pandemic
Ranjan K. Mohapatra, Venkataramana Kandi, Hardeep Singh Tuli, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3506-3508
Open Access | Times Cited: 47
Delta variant (B.1.617.2) of SARS-CoV-2: current understanding of infection, transmission, immune escape, and mutational landscape
Manojit Bhattacharya, Srijan Chatterjee, Ashish Ranjan Sharma, et al.
Folia Microbiologica (2022) Vol. 68, Iss. 1, pp. 17-28
Open Access | Times Cited: 40
Psychological Toll of the COVID-19 Pandemic: An In-Depth Exploration of Anxiety, Depression, and Insomnia and the Influence of Quarantine Measures on Daily Life
Musheer A. Aljaberi, Mohammed A. Al‐Sharafi, Md Uzir Hossain Uzir, et al.
Healthcare (2023) Vol. 11, Iss. 17, pp. 2418-2418
Open Access | Times Cited: 34
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
The SARS‐CoV‐2 Omicron Variant and its Multiple Sub‐lineages: Transmissibility, Vaccine Development, Antiviral Drugs, Monoclonal Antibodies, and Strategies for Infection Control – a Review
Ranjan K. Mohapatra, Sarika Verma, Venkataramana Kandi, et al.
ChemistrySelect (2023) Vol. 8, Iss. 9
Open Access | Times Cited: 17
Sub‐lineages of the SARS‐CoV‐2 Omicron variants: Characteristics and prevention
Ailan Xu, Bixia Hong, Fuxing Lou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 25
Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update
Ranjan K. Mohapatra, Nahed A. El‐Shall, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 24
Current status of recombinase polymerase amplification technologies for the detection of pathogenic microorganisms
Shanshan Zhang, Mingyuan Duan, Shuang Li, et al.
Diagnostic Microbiology and Infectious Disease (2023) Vol. 108, Iss. 1, pp. 116097-116097
Closed Access | Times Cited: 15
The vaccine hesitancy continuum among hesitant adopters of the COVID‐19 vaccine
Ramey Moore, Rachel S. Purvis, Don E. Willis, et al.
Clinical and Translational Science (2022) Vol. 15, Iss. 12, pp. 2844-2857
Open Access | Times Cited: 21
A study on the effect of natural products against the transmission of B.1.1.529 Omicron
Samar Sami Alkafaas, Abanoub Mosaad Abdallah, Aya Misbah Hussien, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 11
Current Updates on Variants of SARS‐CoV‐ 2: Systematic Review
Mulat Erkihun, Bayu Ayele, Zelalem Asmare, et al.
Health Science Reports (2024) Vol. 7, Iss. 11
Open Access | Times Cited: 4
Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
Hitesh Dighe, Prasad Sarkale, Deepak Y. Patil, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1962-1962
Open Access | Times Cited: 17
SARS-CoV-2 emerging Omicron subvariants with a special focus on BF.7 and XBB.1.5 recently posing fears of rising cases amid ongoing COVID-19 pandemic
Kuldeep Dhama, Deepak Chandran, Hitesh Chopra, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1215-1221
Open Access | Times Cited: 17
The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 764-764
Open Access | Times Cited: 10
Cerebral small vessel injury in mice with damage to ACE2‐expressing cerebral vascular endothelial cells and post COVID‐19 patients
Jie-Ping Lu, Xin Zuo, Aoling Cai, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 3
Turning point: A new global COVID‐19 wave or a signal of the beginning of the end of the global COVID‐19 pandemic?
Kaixi Ding, Wei Jiang, Chunping Xiong, et al.
Immunity Inflammation and Disease (2022) Vol. 10, Iss. 4
Open Access | Times Cited: 15
Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination
Misaki Sasanami, Marie Fujimoto, Taishi Kayano, et al.
Journal of Theoretical Biology (2022) Vol. 559, pp. 111384-111384
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top